Stockbabie NewsFatherMarketNewsMarket Intelligence
Subscribe
MARKETS
Wire · Earnings
Earnings

CORRECTION: AbbVie Lowers FY2026 Adj EPS Guidance from $13.91-$14.11 to $13.87-$14.07 vs $14.08 Est

Jul 31, 2026 · 08:21 AM ET· updated 3h ago

AbbVie (NYSE:ABBV) lowers FY2026 Adj EPS guidance from $13.91-$14.11 to $13.87-$14.07 vs $14.08 analyst estimate..

Share
Why It Matters

AbbVie slightly lowered how much money it expects to make per share next year — just a tiny bit less than it said before. When a company adjusts its expectations down, even a little, it's worth noticing what changed and whether the company still seems healthy overall.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
ABBV253.42
-3.99 (-1.55%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.